Business Context and Reporting Period
Company: ILLUMINA, INC. (ILMN)
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2023
Reporting Period: Preliminary results for the fourth quarter and fiscal year ended January 1, 2023.
Context: The filing discloses a presentation made at the J.P. Morgan Healthcare Conference in San Francisco regarding preliminary financial results. The information is furnished via a transcript attached as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet and index for the Form 8-K. It references the existence of preliminary financial results and non-GAAP reconciliations in attached exhibits but does not contain specific numerical values for the following metrics within the text provided:
- Revenue
- Profit (Net Income)
- Cash Flow
- Margins
- Debt
- Liquidity
Investors must refer to Exhibit 99.1 (Transcript) and Exhibit 99.2 (Reconciliation of preliminary non-GAAP results) for specific data points.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It only confirms that preliminary results for the fourth quarter and full fiscal year 2023 were presented. Specific year-over-year or quarter-over-quarter variances are not listed in the provided content.
Guidance, Outlook, and Risks
Guidance: The filing references "Reconciliation of non-GAAP financial guidance for fiscal year 2023" as Exhibit 99.3, indicating that forward-looking guidance was provided during the conference presentation. However, the specific guidance figures are not included in the text of this filing.
Risks and Contingencies: The filing includes a standard disclaimer stating that the information furnished pursuant to Item 2.02 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section. It also notes the information shall not be incorporated by reference into other filings unless specifically referenced.
Investor Verification Checklist
- Review Exhibit 99.1 (Transcript) for the specific preliminary revenue and earnings figures for Q4 and FY 2023.
- Examine Exhibit 99.2 for the reconciliation between GAAP and non-GAAP results for the fiscal year ended January 1, 2023.
- Check Exhibit 99.3 for the specific non-GAAP financial guidance targets for fiscal year 2023.
- Verify the webcast availability on the Company's Investor Relations website, as noted to remain available for at least 30 days.
- Note that the Interim Chief Financial Officer, Joydeep Goswami, signed the report on January 10, 2023.